COST-EFFECTIVENESS OF SYSTEMATIC SCREENING AND TREATMENT OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) IN UNITED STATES

被引：0
|
作者：
Lau, Anson Tsz Chun [1 ]
DiDomenico, Robert J., Jr. [1 ]
Kim, Kibum [1 ]
机构：
[1] Univ Illinois, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1106-003
引用
收藏
页码：400 / 400
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF DAPAGLIFLOZIN VS. EMPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION
    Rane, A.
    Nechi, R. N.
    Imam, M.
    Zoni, C. R.
    Ndikumukiza, C.
    Karaye, I
    Yunusa, I
    Alanazi, A.
    VALUE IN HEALTH, 2023, 26 (06) : S99 - S99
  • [22] Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fraction
    Achten, Anouk
    Muller, Steven A.
    Sanders-van Wijk, Sandra
    van der Meer, Manon G.
    van der Harst, Pim
    van Tintelen, Peter
    te Riele, Anneline S. J. M.
    van Empel, Vanessa
    Oerlemans, Marish I. F. J.
    Knackstedt, Christian
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [23] Cost-Effectiveness of Quadruple Therapy in Management of Heart Failure With Reduced Ejection Fraction in the United States
    Yan, Brandon W. W.
    Spahillari, Aferdita
    Pandya, Ankur
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2023, 16 (06): : 401 - 410
  • [24] Wild-Type Transthyretin Amyloid Cardiomyopathy A Missed Cause of Heart Failure With Preserved Ejection Fraction With Evolving Treatment Implications
    Liu, Peter P.
    Smyth, David
    CIRCULATION, 2016, 133 (03) : 245 - 247
  • [25] REAL-WORLD MEDICATION ADHERENCE TO TAFAMIDIS TREATMENT IN PATIENTS WITH TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) IN THE US MEDICARE POPULATION
    Kemner, Jason
    Cantu, Cera
    Alvir, Jose
    Chen, Yong
    Sounthonevat, Cindi
    Chung, Haechung
    Prasad, Sapna
    Bhambri, Rahul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 401 - 401
  • [26] Comparative Outcomes of a Transthyretin Amyloid Cardiomyopathy Cohort Versus Patients With Heart Failure With Preserved Ejection Fraction Enrolled in the TOPCAT Trial
    Kim, Morris M.
    Prasad, Mark
    Burton, Yunwoo
    Kolseth, Clinton M.
    Zhao, Yuanzi
    Chandrashekar, Pranav
    Nazer, Babak
    Masri, Ahmad
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (15):
  • [27] International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction
    Yun, S.
    Palladini, G.
    Anderson, L.
    Cariou, E.
    Wang, R.
    Angeli, F. S.
    Garcia-Pavia, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 44 - 45
  • [28] International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction
    Yun, Sergi
    Palladini, Giovanni
    Anderson, Lisa J.
    Cariou, Eve
    Wang, Ronnie
    Angeli, Franca S.
    Ebede, Ben
    Garcia-Pavia, Pablo
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 (04): : 291 - 301
  • [29] Quality of life (QoL) in patients with heart failure with preserved ejection fraction (HFpEF): a systematic review
    Chen, J.
    Hunt, P.
    Khordoc, C.
    Hardy, E.
    Mitchell, C.
    EUROPEAN HEART JOURNAL, 2022, 43 : 780 - 780
  • [30] Cost-Effectiveness of Medical Therapy for Heart Failure With Mildly Reduced and Preserved Ejection Fraction
    Dixit, Neal M.
    Truong, Katie P.
    Vaduganathan, Muthiah
    Ziaeian, Boback
    Fonarow, Gregg C.
    JACC-HEART FAILURE, 2024, 12 (07) : 1226 - 1237
12345